COPD (Covid-Related Chronic Obstructive Lung Disease) is an aggressive viral disease that causes the blocking of respiratory organs’ airways. The disease strikes adults over the age of fifty and children younger than five years old. There is no current cure. Many researchers are currently working on developing vaccines to prevent or suppress the progress of the disease.
COPD is caused by a virus called SARS-Covid-2. It is spread by the same type of respiratory virus that causes SARS, or Superantispasmodic Respiratory Syndrome. Elderly people and those with other serious underlying health conditions such as lung or heart disease seem to be at greater risk for developing serious complications from COPD. It is difficult to accurately identify individuals at risk. Symptoms may occur months before the onset of COPD or may not surface until years after diagnosis. When an individual who has suffered from COPD suffers from any of the following symptoms for a minimum of six months or develops a chronic cough lasting for more than two weeks, they should be evaluated for possible COPD: persistent coughing with little or no breath smoking; wheezing that produces a heavy, steady stream; shortness of breath when breathing; chest pain or discomfort in the upper chest; sudden, persistent, intense chest pressure; and swelling of the lung area, especially the chest wall muscles.
Those who suffer from COVID-19 may also experience shortness of breath, fever, and sore throat. If these symptoms occur on a regular basis, they usually indicate that COPD has developed. Those who do not regularly visit their doctor or are unable to keep to a regular routine may be at increased risk of developing or worsening COPD. They should seek immediate medical care if they experience or know that they are experiencing any of the symptoms listed above.
The symptoms of COPD can be mild to severe. Mild COPD will not cause death, but it can make life uncomfortable and is often referred to as chronic obstructive pulmonary disease (COPD). This type of respiratory disease affects the major organs of the body. In fact, COPD is the number one cause of disability and death in America.
Two different types of respiratory illnesses are caused by COPD, acute and chronic. Acute COPD is the least common. With acute respiratory illness the symptoms are generally similar to those of common cold. Those who experience any of the following symptoms should seek medical attention immediately: runny nose, sore throat, fever, and cough. Those who do not experience any of these symptoms should stay home to avoid spreading the virus.
Coughing is a common symptom for those who suffer from COPD, usually because the illness causes the airways to become blocked, making it difficult to breathe. It is important to note that although symptoms of COPD can include sore throat and fever, they can also include hoarseness, and even pain in the bones or joints. Anyone experiencing these symptoms should immediately call their doctor or health care provider to determine if the problem is COPD or some other illness. It is important to note that the cold sore symptoms of covid-19 are the same symptoms as with cold sores, so if a person already has these symptoms they should avoid kissing someone unless they are treating their cold sore.
A new study discovered that two strains of a highly infectious virus cause most cases of uncomplicated COPD. These viruses, named virus-associated molecular antigen (VAM antiviral syndrome) and non-viral syndrome of acute respiratory syndrome (NVA} are distinct strains of the same virus that causes common colds. These two viruses combine to form a new strain of the virus causing the COPD. Since these two viruses do not always cause uncomplicated COPD, it is possible that some people will develop both viruses and yet never develop COPD. Although this is the case, they still have a risk of developing complications from their condition. The study did not identify how these viruses combine to cause uncomplicated COPD but believe that it is due to an unusual amino acid combination at the base of the virus.
It is unknown how the two viruses interact to cause uncomplicated COPD, but they were found to be present in patients with severe pneumonia who had no previous history of respiratory disease. Researchers believe that the discovery of these two viruses may help to develop a treatment for COPD, or they may lead to the identification of novel types of the virus that can be used to prevent its development. If the virus that causes COPD can be treated successfully, it could be used as the basis for a vaccine to protect against a future epidemic of COPD. Until then, researchers are hopeful that they can learn more about the intricacies of the complicated disease and look for ways to prolong the life of those who suffer from it.